Exelixis
EXEL
#1574
Rank
$10.78 B
Marketcap
$38.55
Share price
-0.36%
Change (1 day)
70.95%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company